Norditropin FlexPro Stungulyf, lausn 10/1,5 mg/ml 冰岛 - 冰岛文 - LYFJASTOFNUN (Icelandic Medicines Agency)

norditropin flexpro stungulyf, lausn 10/1,5 mg/ml

novo nordisk a/s* - somatropinum inn - stungulyf, lausn - 10/1,5 mg/ml

Norditropin NordiFlex Stungulyf, lausn í áfylltum lyfjapenna 5 mg /1,5 ml 冰岛 - 冰岛文 - LYFJASTOFNUN (Icelandic Medicines Agency)

norditropin nordiflex stungulyf, lausn í áfylltum lyfjapenna 5 mg /1,5 ml

novo nordisk a/s* - somatropinum inn - stungulyf, lausn í áfylltum lyfjapenna - 5 mg /1,5 ml

Norditropin NordiFlex Stungulyf, lausn í áfylltum lyfjapenna 15 mg/1,5 ml 冰岛 - 冰岛文 - LYFJASTOFNUN (Icelandic Medicines Agency)

norditropin nordiflex stungulyf, lausn í áfylltum lyfjapenna 15 mg/1,5 ml

novo nordisk a/s* - somatropinum inn - stungulyf, lausn í áfylltum lyfjapenna - 15 mg/1,5 ml

Norditropin NordiFlex Stungulyf, lausn í áfylltum lyfjapenna 10 mg/1,5 ml 冰岛 - 冰岛文 - LYFJASTOFNUN (Icelandic Medicines Agency)

norditropin nordiflex stungulyf, lausn í áfylltum lyfjapenna 10 mg/1,5 ml

novo nordisk a/s* - somatropinum inn - stungulyf, lausn í áfylltum lyfjapenna - 10 mg/1,5 ml

Firmagon 欧盟 - 冰岛文 - EMA (European Medicines Agency)

firmagon

ferring pharmaceuticals a/s - degarelix - blöðruhálskirtli - innkirtla meðferð - firmagon is a gonadotrophin releasing hormone (gnrh) antagonist indicated:- for treatment of adult male patients with advanced hormone-dependent prostate cancer. - for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. - as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.

Ngenla 欧盟 - 冰岛文 - EMA (European Medicines Agency)

ngenla

pfizer europe ma eeig - somatrogon - growth and development - sterum og undirstÚku hormÓn og hliÐstÆÐum - indicated for the long-term treatment of paediatric patients with growth disturbance due to insufficient secretion of growth hormone.

Prid delta Leggangainnlegg 1,55 g 冰岛 - 冰岛文 - LYFJASTOFNUN (Icelandic Medicines Agency)

prid delta leggangainnlegg 1,55 g

ceva santé animale* - progesteronum inn - leggangainnlegg - 1,55 g

Degarelix Accord 欧盟 - 冰岛文 - EMA (European Medicines Agency)

degarelix accord

accord healthcare s.l.u. - degarelix acetate - blöðruhálskirtli - other hormone antagonists and related agents - degarelix accord is a gonadotrophin releasing hormone (gnrh) antagonist indicated:for treatment of adult male patients with advanced hormone-dependent prostate cancer. for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.

Erleada 欧盟 - 冰岛文 - EMA (European Medicines Agency)

erleada

janssen-cilag international nv - apalutamide - blöðruhálskirtli - innkirtla meðferð - erleada er ætlað:í fullorðnir menn í meðferð ekki sjúklingum gelding þola krabbamein í blöðruhálskirtli (nmcrpc) sem eru á mikil hætta á að fá sjúklingum sjúkdómur. í fullorðnir menn fyrir meðferð af sjúklingum hormón-viðkvæm krabbamein í blöðruhálskirtli (mhspc) ásamt andrógen skort meðferð (adt).

Zoladex Vefjalyf 10,8 mg 冰岛 - 冰岛文 - LYFJASTOFNUN (Icelandic Medicines Agency)

zoladex vefjalyf 10,8 mg

astrazeneca ab - goserelinum acetat - vefjalyf - 10,8 mg